Chapter RDF

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...

• Anosognosia for hemiplegia: A confabulatory state
• Ansa pancreatica
• Anterior colporrhaphy
• Anterior Segment Evaluation
• Anterior vaginal wall suspension
• Anticholinergics
• Anticipating and managing risk in a culture of quality, safety, and value
• Anticipation and the neural response to threat
• Anticoagulation for Continuous Renal Replacement Therapy
• Antidepressants
• Antiemetics
• Antigen delivery systems i: Nonliving microparticles, liposomes, and immune stimulating complexes (iscoms)
• Antigen handling and presentation by mucosal dendritic cells and macrophages
• Antigen receptor genes, gene products, and co-receptors
• Antigen receptor genes, gene products, and co-receptors
• Antigens and Antibodies
• Antigens and antigen presentation
• Antigens and antigen processing
• Antiparasitic Agents
• Antiparkinsonian drugs.
• Antiviral Agents
• Antiviral Agents
• Antiviral therapy
• Antiviral therapy of HSV-1 and-2
• Anxiety disorders
• Anxiety disorders
• Aortic sinus cusps for catheter ablation of supraventricular and ventricular arrhythmias
• Apheresis in Solid Organ Transplantation
• Apoptosis in Neurodegenerative Disease
• Apoptosis in neurodegenerative diseases

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• more...